[1]杨槟伊,刘小梅,陈鑫,等.SNHG7-miR-653-5p-STAT2反馈通路在神经母细胞瘤进展中的调节作用研究[J].临床小儿外科杂志,2022,21(02):128-135.[doi:10.3760/cma.j.cn.101785-201910074-006]
　Yang Bingyi,Liu Xiaomei,Chen Xin,et al.Role of SNHG7-miR-653-5p-STAT2 feedback loop in regulating neuroblastoma progression[J].Journal of Clinical Pediatric Surgery,2022,21(02):128-135.[doi:10.3760/cma.j.cn.101785-201910074-006]
点击复制

SNHG7-miR-653-5p-STAT2反馈通路在神经母细胞瘤进展中的调节作用研究

《临床小儿外科杂志》[ISSN:1671-6353/CN:43-1380/R] 卷: 第21卷 期数: 2022年02期 页码: 128-135 栏目: 专题·儿童神经母细胞瘤 出版日期: 2022-02-28
Title:
Role of SNHG7-miR-653-5p-STAT2 feedback loop in regulating neuroblastoma progression
作者:
杨槟伊1;  刘小梅1;  陈鑫1;  陈伟明2;  范煦3;  李富江1;  鹿洪亭4
1 青岛大学附属医院小儿外科, 青岛 266000;
2 青岛大学, 青岛 266071;
3 胜利油田中心医院儿科, 东营 257034;
4 青岛大学附属妇女儿童医院小儿外科, 青岛 266011
Author(s):
Yang Bingyi1;  Liu Xiaomei1;  Chen Xin1;  Chen Weiming2;  Fan Xu3;  Li Fujiang1;  Lu Hongting4
1 Affiliated Hospital of Qingdao University, Qingdao 266000, China;
2 Qingdao University, Qingdao 266071, China;
3 Shengli Oilfield Central Hospital of Pediatrics, Dongying 257034, China;
4 Women and Children’s Hospital Affiliated to Qingdao University, Qingdao 266011, China
关键词:
神经母细胞瘤/病因学; 神经母细胞瘤/预防和控制
Keywords:
Neuroblastoma/ET; Neuroblastoma/PC
DOI:
10.3760/cma.j.cn.101785-201910074-006
摘要:
目的 研究lncRNA SNHG7在神经母细胞瘤（neuroblastoma，NB）进展中的作用，以及SNHG7-miR-653-5p-STAT2反馈通路在神经母细胞瘤进展中的调节作用。方法 从青岛大学附属医院收治的NB患儿体内获得92对NB组织及相邻非肿瘤组织。采用qRT-PCR检测SNHG7在神经母细胞瘤肿瘤组织及细胞中的表达情况。采用Kaplan-Meier分析神经母细胞瘤患儿的总体存活率。采用比色法（MTT法）和集落形成法检测SNHG7对SK-N-SH和SH-SY5Y细胞的作用。采用Transwell侵袭及迁移试验检测SK-N-SH和SH-SY5Y细胞的侵袭和迁移能力。采用荧光素酶检测miR-653-5p和SNHG7、STAT2之间的作用。采用RIP测定及RNA下拉测定检验SNHG7和miR-653-5p在NB中的相对表达情况。采用Spearman相关分析探究SNHG7与miR-653-5p、STAT2的相关性。结果 qRT-PCR显示，92对NB组织及相邻非肿瘤组织中，肿瘤组织（n=53）中SNHG7的表达量高于非肿瘤组织（n=39）。SNHG7高表达的NB患儿（n=53）总生存期随月份的增加而逐渐降低，SNHG7低表达的NB患儿（n=39）总生存期随月份的增加也逐渐降低，两组差异有统计学意义（P=0.004）。细胞功能试验：①MTT法和集落形成法检测结果显示，SNHG7的下调对SK-N-SH和SH-SY5Y细胞的存活和增殖有明显抑制作用；②Transwell试验检测结果显示，敲低SNHG7可明显抑制SK-N-SH和SH-SY5Y细胞的细胞迁移和侵袭能力（P<0.05）；③荧光素酶检测显示，miR-653-5p能降低SNHG7-WT（野生型）的荧光素酶活性，且miR-653-5p与STAT2-WT（野生型）之间存在特异性的相互作用。Spearman相关分析显示：①NB组织中SNHG7与miR-653-5p表达水平呈负相关（r=-0.281，P=0.007）；②STAT2的表达量与NB组织中miR-653-5p表达水平呈负相关（r=-0.295，P=0.004），STAT2的表达量与NB组织中SNHG7表达水平呈正相关（r=0.296，P=0.004）。结论 SNHG7通过miR-653-5p/STAT2通路促使NB进展，这为NB提供了一个新的治疗靶点和预测预后的生物标志物。
Abstract:
Objective To explore the role of lncRNASNHG7 in the progression of neuroblastoma (NB) and examine the regulatory role of snhg7-mir-653-5p-stat2 feedback pathway in NB.Long noncoding RNAs (lncRNAs) have been implicated in the pathogenesis of various cancers, including neuroblastoma (NB).However, the role of lncRNASNHG7 in NB progression remains elusive.Methods The expression of SNHG7 in NB tissues and cells was detected by quantitative realtime-polymerase chain reaction (qRT-PCR).Cellular invasion and migration were detected by Transwell invasion and migration assay.Luciferase assay was utilized for detecting the interaction between mir-653-5p, SNHG7 and STAT2.The relative expressions of SNHG7 and mir-653-5p in NB were determined by RNA-binding protein immunoprecipitation (RIP) assay and RNA pull-down assay.Spearman’s correlation curve was employed for examining the relationship between SNHG7 and mir-653-5p and STAT2.Overall survival was measured by Kaplan-Meier analysis.The effects of SNHG7 on SK-N-SH/SH-SY5Y cells were determined by methylthiazolyldiphenyl-tetrazolium bromide (MTT) and colony formation.Results qRT-PCR demonstrated that, among 92 pairs of neuroblastoma (NB) and adjacent non-tumor tissues, expression quantity of SNHG7 was higher in tumor tissues (n=53) than that in non-tumor tissues (n=39).Kaplan Meier analysis revealed that overall survival decreased with advancing months in high SNHG7 patients (n=53) and similarly in low SNHG7 counterparts (n=39) with a lower extent (P=0.004).An up-regulation of SNHG7 was correlated with a poor overall survival rate of NB patients.Cell function test indicated that a down-regulation of SNHG7 by MTT and colony formation significantly suppressed the survival and proliferation of SK-N-SH/SH-SY5Y cells.Transwell test indicated that knocking down SNHG7 significantly suppressed the migration and invasion of SK-N-SH/SH-SY5Y cells (P<0.01).Luciferase assay revealed that miR-653-5p lowered the luciferase activity of SNHG7-wt (wildtype).And a specific interaction existed between miR-653-5p and STAT2-wt (wildtype).Spearman’s correlation curve analysis indicated that SNHG7 in NB tissues was negatively correlated with miR-653-5p (r=-0.281, P=0.007).The expression of STAT2 was negatively correlated with miR-653-5p in NB tissues (r=-0.295, P=0.004) and positively correlated with SNHG7 in NB tissues (r=0.296, P=0.004).These data suggested that SNHG7 played a role in NB progression by regulating the pathway of miR-653-5p/STAT2. Conclusion SNHG7 promotes NB progression through the pathway of miR-653-5p/STAT2.Thus it may provide a novel therapeutic target and prognostic biomarker for NB.

参考文献/References:

[1] Maris JM.Recent advances in neuroblastoma[J].N Engl J Med,2010,362(23):2202-2011.DOI:10.1056/NEJMra0804577.
[2] Suo C,Deng W,Vu TN,et al.Accumulation of potential driver genes with genomic alterations predicts survival of high-risk neuroblastoma patients[J].Biol Direct,2018,13(1):14.DOI:10.1186/s13062-018-0218-5.
[3] Filipowicz W,Bhattacharyya SN,Sonenberg N.Mechanisms of post-transcriptional regulation by microRNAs:are the answers in sight?[J].Nat Rev Genet,2008,9(2):102-114.DOI:10.1038/nrg2290.
[4] Ridinger J,Koeneke E,Kolbinger FR,et al.Dual role of HDAC10 in lysosomal exocytosis and DNA repair promotes neuroblastoma chemoresistance[J].Sci Rep,2018,8(1):10039.DOI:10.1038/s41598-018-28265-5.
[5] Zhou H,Zhuo Z,Chen S,et al.Polymorphisms in MYCN gene and neuroblastoma risk in Chinese children:a 3-center case-control study[J].Cancer Manag Res,2018,10:1807-1816.DOI:10.2147/CMAR.S168515.
[6] Uhl KL,Schultz CR,Geerts D,et al.Harmine,a dual-specificity tyrosine phosphorylation-regulated kinase (DYRK) inhibitor induces caspase-mediated apoptosis in neuroblastoma[J].Cancer Cell Int,2018,18:82.DOI:10.1186/s12935-018-0574-3.
[7] Wu W,Jingbo S,Xu W,et al.S-trityl-L-cysteine,a novel Eg5 inhibitor,is a potent chemotherapeutic strategy in neuroblastoma[J].Oncol Lett,2018,16(1):1023-1030.DOI:10.3892/ol.2018.8755.
[8] Schmitt AM,Chang HY.Long noncoding RNAs in cancer pathways[J].Cancer Cell,2016,29(4):452-463.DOI:10.1016/j.ccell.2016.03.010.
[9] Zhao M,Sun L,Sun S,et al.The 42.1 and 53.7 kDa bands in SDS-PAGE of R-phycoerythrin from Polysiphonia urceolata[J].Int J Biol Macromol,2013,60:405-411.DOI:10.1016/j.ijbiomac.2013.06.009.
[10] Marchese FP,Raimondi I,Huarte M.The multidimensional mechanisms of long noncoding RNA function[J].Genome Biol,2017,18(1):206.DOI:10.1186/s13059-017-1348-2.
[11] Li Y,Zeng C,Hu J,et al.Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression[J].J Hematol Oncol,2018,11(1):89.DOI:10.1186/s13045-018-0632-2.
[12] She K,Huang J,Zhou H,et al.lncRNA-SNHG7 promotes the proliferation,migration and invasion and inhibits apoptosis of lung cancer cells by enhancing the FAIM2 expression[J].Oncol Rep,2016,36(5):2673-2680.DOI:DOI:10.3892/or.2016.5105.
[13] Filipowicz W,Bhattacharyya SN,Sonenberg N.Mechanisms of post-transcriptional regulation by microRNAs:are the answers in sight?[J].Nat Rev Genet,2008,9(2):102-114.DOI:10.1038/nrg2290.
[14] Tay Y,Rinn J,Pandolfi PP.The multilayered complexity of ceRNA crosstalk and competition[J].Nature,2014,505(7483):344-352.DOI:10.1038/nature12986.
[15] Tu J,Zhao Z,Xu M,et al.NEAT1 upregulates TGF-β1 to induce hepatocellular carcinoma progression by sponging hsa-mir-139-5p[J].J Cell Physiol,2018,233(11):8578-8587.DOI:10.1002/jcp.26524.
[16] Wang R,Zhang T,Yang Z,et al.Long non-coding RNA FTH1P3 activates paclitaxel resistance in breast cancer through miR-206/ABCB1[J].J Cell Mol Med,2018,22(9):4068-4075.DOI:10.1111/jcmm.13679.
[17] Shan Y,Ma J,Pan Y,et al.LncRNA SNHG7 sponges miR-216b to promote proliferation and liver metastasis of colorectal cancer through upregulating GALNT1[J].Cell Death Dis,2018,9(7):722.DOI:10.1038/s41419-018-0759-7.
[18] Qi H,Wen B,Wu Q,et al.Long noncoding RNA SNHG7 accelerates prostate cancer proliferation and cycle progression through cyclin D1 by sponging miR-503[J].Biomed Pharmacother,2018,102:326-332.DOI:10.1016/j.biopha.2018.03.011.
[19] Zhao W,Fu H,Zhang S,et al.LncRNA SNHG16 drives proliferation,migration,and invasion of hemangioma endothelial cell through modulation of miR-520d-3p/STAT3 axis[J].Cancer Med,2018,7(7):3311-3320.DOI:10.1002/cam4.1562.
[20] Bevilacqua V,Gioia U,Di Carlo V,et al.Identification of linc-NeD125,a novel long non coding RNA that hosts miR-125b-1 and negatively controls proliferation of human neuroblastoma cells[J].RNA Biol,2015,12(12):1323-1337.DOI:10.1080/15476286.2015.1096488.
[21] Russell MR,Penikis A,Oldridge DA,et al.CASC15-S Is a tumor suppressor lncRNA at the 6p22 neuroblastoma susceptibility locus[J].Cancer Res,2015,75(15):3155-3166.DOI:10.1158/0008-5472.CAN-14-3613
[22] Ren J,Yang Y,Xue J,et al.Long noncoding RNA SNHG7 promotes the progression and growth of glioblastoma via inhibition of miR-5095[J].Biochem Biophys Res Commun,2018,496(2):712-718.DOI:10.1016/j.bbrc.2018.01.109.
[23] Wang M,Cai WR,Meng R,et al.miR-485-5p suppresses breast cancer progression and chemosensitivity by targeting survivin[J].Biochem Biophys Res Commun,2018,501(1):48-54.DOI:10.1016/j.bbrc.2018.04.129.
[24] Diao L,Wang S,Sun Z.Long noncoding RNA GAPLINC promotes gastric cancer cell proliferation by acting as a molecular sponge of miR-378 to modulate MAPK1 expression[J].Onco Targets Ther,2018,11:2797-2804.DOI:10.2147/OTT.S165147.
[25] Liu Y,Yang L,Yin J,et al.MicroRNA-15b deteriorates hypoxia/reoxygenation-induced cardiomyocyte apoptosis by downregulating Bcl-2 and MAPK3[J].J Investig Med,2018,66(1):39-45.DOI:10.1136/jim-2017-000485.
[26] Shuai K,Liu B.Regulation of JAK-STAT signalling in the immune system[J].Nat Rev Immunol,2003,3(11):900-911.DOI:10.1038/nri1226.
[27] Johansen C,Rittig AH,Mose M,et al.STAT2 is involved in the pathogenesis of psoriasis by promoting CXCL11 and CCL5 production by keratinocytes[J].PLoS One,2017,12(5):e0176994.DOI:10.1371/journal.pone.0176994.
[28] Liang Z,Gao LH,Cao LJ,et al.Detection of STAT2 in early stage of cervical premalignancy and in cervical cancer[J].Asian Pac J Trop Med,2012,5(9):738-742.DOI:10.1016/S1995-7645(12)60117-5.
[29] Ogony J,Choi HJ,Lui A,et al.Interferon-induced transmembrane protein 1(IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2(STAT2)-dependent manner[J].Breast Cancer Res,2016,18(1):25.DOI:10.1186/s13058-016-0683-7.

相似文献/References:

[1]张梅慧,姜大朋.先天性神经母细胞瘤发病机制与临床特点的研究进展[J].临床小儿外科杂志,2022,21(02):141.[doi:10.3760/cma.j.cn.101785-202105045-008]
　Zhang Meihui,Jiang Dapeng.Pathogenesis and clinical characteristics of congenital neuroblastoma[J].Journal of Clinical Pediatric Surgery,2022,21(02):141.[doi:10.3760/cma.j.cn.101785-202105045-008]

备注/Memo

收稿日期:2021-10-31。
基金项目:青岛市民生科技计划项目（18-6-1-71-nsh）
通讯作者:鹿洪亭,Email:luhongting@126.com

更新日期/Last Update: 1900-01-01